Skip to main content
Figure 1 | Annals of Clinical Microbiology and Antimicrobials

Figure 1

From: In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases

Figure 1

Activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus a multidrug resistant A. baumannii OXA-23 clones using 2 Etest method. A) Polymyxin and imipenem versus OXA-23 clone 2, B) Polymyxin and rifampicin versus OXA-23 clone 2, C) Polymyxin and azithromycin versus OXA-23 clone 1

Back to article page